Member Info for Gamflin

Tyke, as long as Kathleen continues to hold I’m sure we’ll be fine.

See Oct 21 newsletter for the benefits/ potential of Zero G

And this from Oct 22 newsletter

Work is also underway for the submission of a de novo FDA application for IB Zero G™ market clearance. As determined by the FDA reviewers, no currently marketed device compares to IB Zero G, which could be used as a predicate to establish substantial equivalence. The next step is to schedule a pre-submission meeting with the FDA for guidance and clarification.

Zero G, there 16500 mri scanners in the US , this tech might be applicable to a large percentage of scans.

Let’s say ( pucks a figure out of the air) $12000 for each one($1000 a month( tens of $ per scan)) I won’t do the math its there for all to see. Of course we wouldn’t be on all scanners, or would we? But there’s the rest of the world. Access via GE/ Mayo/ Google could gain an extraordinary penetration ( oh there’s currently no alternative). TB holds all the cards here no one can have it on the cheep. Should IQAI get zero G over the line ( which could happen tomorrow) 50p will be a distant memory.

Not ramping just saying in the words of Lilly James Hello possible.

Https://x.com/iqai_ib/status/1704559885935878503?s=46&t=OQmVqG_pDn9iOzGNWA5_JQ

One can feel the momentum building here, much risk has been removed in the last few weeks.

Certainly looks like it, just their silly games.

Https://twitter.com/kobeissiletter/status/1681412069592055823?s=12

Whilst we’re be being positive let’s not forget contrast agent free imaging, too novel for the FDA to evaluate we must be ahead of the rest, if that drops we really will be off to the races.

I haven’t seen a price target that has anything much in for Royston so perhaps a tad more than most are suggesting.

PR, given a 21 day untreated survival these were late stage cases treatment much earlier could have a profound impact

Https://twitter.com/iqai_ib/status/1663624969694384130?s=46&t=OQmVqG_pDn9iOzGNWA5_JQ

Nice post Trek, the risk/ reward metric here is a little bonkers.

Absolutely agree John Cas C if good

Would be a company making result it’s the path to 160mmcftpd plus 4000bls ( net to TXP). Royston would take much longer to get to those type revenues

I’ve added 250k today,14.20 delayed one hour printed as a sell. Someone not ready to let it rise just yet.

Perhaps we should be making honey approximately $130 per kilogram???

Not forgetting the $5m vat rebate if it ever gets paid, it been talked about for many months now.

Things seem to be progressing in a timely manner, the completion of this piece of apparatus would suggest that they intend to complete the liquids pipeline sooner rather than later, the assumption being if they truck the liquids they would be metered at point of delivery.

The 19949 shown as a sell is a buy.

It was addressed to the John of this thread ( without the RE) the primary concern of this board is the failure of the company to develop discoveries that will produce hundreds of million of dollars in revenue and how this can be avoided in the future. Whilst the poster comments seem to be trying to in-still fear of a falling SP. People buy and sell for many reasons but how many long term holder’s would sell significantly ahead of Cascadura hook up so next weeks SP is of little consequence to most. Oh and this post is for Dunderhead, still holding a million plus shares? ATB.

John , not sure your comments are relevant to this board.

The optimist in me hopes they’re flowing gas but stabilising/ optimising before informing the market. We shall see.News of the EIA for Cascadura is equally important, it will interesting to see how long it takes NGC to build the pipeline.